Copyright
©The Author(s) 2020.
World J Transplant. Jul 29, 2020; 10(7): 183-190
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.183
Published online Jul 29, 2020. doi: 10.5500/wjt.v10.i7.183
Table 2 Antiviral drugs for cytomegalovirus prophylaxis and treatment in liver transplant patients
| Drug | Route | Prophylaxis dose | Treatment dose | Side effects |
| Ganciclovir | IV | 5 mg/kg daily | 5 mg/kg twice a day | Bone marrow suppression |
| Valganciclovir | Oral | 900 mg once a day | 900 mg twice a day | Leukopenia |
| Foscarnet | IV | - | 60 mg/kg every 8 h or 90 mg/kg every 12 h | Nephrotoxicity |
| Cidofovir | IV | - | 5 mg/kg weekly × 2, then every 2 wk | Nephrotoxicity |
- Citation: Lizaola-Mayo BC, Rodriguez EA. Cytomegalovirus infection after liver transplantation. World J Transplant 2020; 10(7): 183-190
- URL: https://www.wjgnet.com/2220-3230/full/v10/i7/183.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i7.183